Cargando…
Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion
BACKGROUND: We report our findings in three cases of unilateral macular edema associated with retinal vein occlusion (RVO) that improved after successful treatment of systemic hypertension alone. METHODS: All three cases had systemic hypertension but no diabetes mellitus or other ocular diseases ass...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037305/ https://www.ncbi.nlm.nih.gov/pubmed/24876761 http://dx.doi.org/10.2147/OPTH.S63368 |
_version_ | 1782318238106910720 |
---|---|
author | Kida, Teruyo Morishita, Seita Kakurai, Keigo Suzuki, Hiroyuki Oku, Hidehiro Ikeda, Tsunehiko |
author_facet | Kida, Teruyo Morishita, Seita Kakurai, Keigo Suzuki, Hiroyuki Oku, Hidehiro Ikeda, Tsunehiko |
author_sort | Kida, Teruyo |
collection | PubMed |
description | BACKGROUND: We report our findings in three cases of unilateral macular edema associated with retinal vein occlusion (RVO) that improved after successful treatment of systemic hypertension alone. METHODS: All three cases had systemic hypertension but no diabetes mellitus or other ocular diseases associated with macular edema. All patients were treated only with medication for systemic hypertension. Optical coherence tomography was performed to determine the foveal thickness before and after treatment. RESULTS: Case one was a 72-year-old woman with a central RVO who had macular edema in her left eye and a visual acuity (VA) of 20/50. Her blood pressure (BP) was 169/96 mmHg. One month after the initiation of a calcium blocker to treat her systemic hypertension, her BP was decreased, macular edema was reduced, and her VA improved to 20/20. Case two was a 62-year-old woman with branch RVO. Her VA was 20/40 and her BP was 165/97 mmHg. Six weeks after initiation of medication to treat her systemic hypertension, her RVO-related macular edema had decreased and her VA improved to 20/20. Case three was a 71-year-old man with branch RVO. His VA was 20/50 and his BP was 165/87 mmHg. One month after initiation of treatment for systemic hypertension, his RVO-related macular edema had disappeared and his VA improved to 20/20. All three cases had nonischemic RVO by fluorescein angiography, and they did not develop ischemic changes for at least 1 year. CONCLUSION: The reduction of macular edema following a decrease in the systemic hypertension suggests that the edema was most likely caused by leakage of fluids from the blood vessels. We recommend that the blood pressure should be measured in all patients with macular edema before initiating intravitreal anti-VEGF therapy. |
format | Online Article Text |
id | pubmed-4037305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-40373052014-05-29 Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion Kida, Teruyo Morishita, Seita Kakurai, Keigo Suzuki, Hiroyuki Oku, Hidehiro Ikeda, Tsunehiko Clin Ophthalmol Case Series BACKGROUND: We report our findings in three cases of unilateral macular edema associated with retinal vein occlusion (RVO) that improved after successful treatment of systemic hypertension alone. METHODS: All three cases had systemic hypertension but no diabetes mellitus or other ocular diseases associated with macular edema. All patients were treated only with medication for systemic hypertension. Optical coherence tomography was performed to determine the foveal thickness before and after treatment. RESULTS: Case one was a 72-year-old woman with a central RVO who had macular edema in her left eye and a visual acuity (VA) of 20/50. Her blood pressure (BP) was 169/96 mmHg. One month after the initiation of a calcium blocker to treat her systemic hypertension, her BP was decreased, macular edema was reduced, and her VA improved to 20/20. Case two was a 62-year-old woman with branch RVO. Her VA was 20/40 and her BP was 165/97 mmHg. Six weeks after initiation of medication to treat her systemic hypertension, her RVO-related macular edema had decreased and her VA improved to 20/20. Case three was a 71-year-old man with branch RVO. His VA was 20/50 and his BP was 165/87 mmHg. One month after initiation of treatment for systemic hypertension, his RVO-related macular edema had disappeared and his VA improved to 20/20. All three cases had nonischemic RVO by fluorescein angiography, and they did not develop ischemic changes for at least 1 year. CONCLUSION: The reduction of macular edema following a decrease in the systemic hypertension suggests that the edema was most likely caused by leakage of fluids from the blood vessels. We recommend that the blood pressure should be measured in all patients with macular edema before initiating intravitreal anti-VEGF therapy. Dove Medical Press 2014-05-16 /pmc/articles/PMC4037305/ /pubmed/24876761 http://dx.doi.org/10.2147/OPTH.S63368 Text en © 2014 Kida et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Case Series Kida, Teruyo Morishita, Seita Kakurai, Keigo Suzuki, Hiroyuki Oku, Hidehiro Ikeda, Tsunehiko Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion |
title | Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion |
title_full | Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion |
title_fullStr | Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion |
title_full_unstemmed | Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion |
title_short | Treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion |
title_sort | treatment of systemic hypertension is important for improvement of macular edema associated with retinal vein occlusion |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037305/ https://www.ncbi.nlm.nih.gov/pubmed/24876761 http://dx.doi.org/10.2147/OPTH.S63368 |
work_keys_str_mv | AT kidateruyo treatmentofsystemichypertensionisimportantforimprovementofmacularedemaassociatedwithretinalveinocclusion AT morishitaseita treatmentofsystemichypertensionisimportantforimprovementofmacularedemaassociatedwithretinalveinocclusion AT kakuraikeigo treatmentofsystemichypertensionisimportantforimprovementofmacularedemaassociatedwithretinalveinocclusion AT suzukihiroyuki treatmentofsystemichypertensionisimportantforimprovementofmacularedemaassociatedwithretinalveinocclusion AT okuhidehiro treatmentofsystemichypertensionisimportantforimprovementofmacularedemaassociatedwithretinalveinocclusion AT ikedatsunehiko treatmentofsystemichypertensionisimportantforimprovementofmacularedemaassociatedwithretinalveinocclusion |